Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP20895.RAt8BGe42DWktnWdzmb1-H2wo3Gug7biFre9-Hk2C69Gk130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20895.RAt8BGe42DWktnWdzmb1-H2wo3Gug7biFre9-Hk2C69Gk130_provenance.
• NP20704.RATHySrDN5rffh6IKLIr5LBVuNtvsR0aUuiGpM4iQFF1k130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20704.RATHySrDN5rffh6IKLIr5LBVuNtvsR0aUuiGpM4iQFF1k130_provenance.
• NP23598.RAzlUb2kKZesBi124omRyFQ14xiIwA4qpC8xFORuYe0bM130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23598.RAzlUb2kKZesBi124omRyFQ14xiIwA4qpC8xFORuYe0bM130_provenance.
• NP8609.RA-qh1x4ZIECA3mHQbO0O2zq5NjaMxFl9_gQdvZ-JKNak130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8609.RA-qh1x4ZIECA3mHQbO0O2zq5NjaMxFl9_gQdvZ-JKNak130_provenance.
• NP16814.RA5MDWsdafi0tACrZcZqfY2OHJi9i0pMDFEtf5naVyk5k130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP16814.RA5MDWsdafi0tACrZcZqfY2OHJi9i0pMDFEtf5naVyk5k130_provenance.
• NP31464.RAZSCCa5oHxtPQPltVpOwGB3_PLqy6XFAAZ6ZwQrY9Kf0130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP31464.RAZSCCa5oHxtPQPltVpOwGB3_PLqy6XFAAZ6ZwQrY9Kf0130_provenance.
• NP33569.RAaKn74d-UHpMzzoTt3MaMltSIhAc10VlYyGTP1DlX_dc130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33569.RAaKn74d-UHpMzzoTt3MaMltSIhAc10VlYyGTP1DlX_dc130_provenance.
• assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP33618.RAPyJv7gu0EMRsSlHDH2GsKpPJgxy_pL-MOn2KlqTkJ8U130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33618.RAPyJv7gu0EMRsSlHDH2GsKpPJgxy_pL-MOn2KlqTkJ8U130_provenance.
• NP11032.RAhLxb6bxVCDkk8xgsvEbZzmiGArwOy4BpXv5p5Xr3RM0130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP11032.RAhLxb6bxVCDkk8xgsvEbZzmiGArwOy4BpXv5p5Xr3RM0130_provenance.
• NP12228.RAdAGvnEsV5rPBXE4bYvdi3DO1a4XV3bFxRDb2NDA3IwU130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP12228.RAdAGvnEsV5rPBXE4bYvdi3DO1a4XV3bFxRDb2NDA3IwU130_provenance.
• NP15955.RAWjcJGH23VxSZAxFHfssvb3BMhaV4g2Hj0HWZByQ28K8130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP15955.RAWjcJGH23VxSZAxFHfssvb3BMhaV4g2Hj0HWZByQ28K8130_provenance.
• assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP31814.RAbyKBaFE1LXIg6rffJR1HJIQAgPuNaP8S_6ruY3hrfYQ130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP31814.RAbyKBaFE1LXIg6rffJR1HJIQAgPuNaP8S_6ruY3hrfYQ130_provenance.
• NP34104.RAejXbOT_UsuGz4d_UbW_vwG_uCGgdZefiaN2K9QbjTMg130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP34104.RAejXbOT_UsuGz4d_UbW_vwG_uCGgdZefiaN2K9QbjTMg130_provenance.
• NP6869.RAyYYToRTpGkdoq9GkuTujtg3iTFbB7pyKxvtVQjUWfTg130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP6869.RAyYYToRTpGkdoq9GkuTujtg3iTFbB7pyKxvtVQjUWfTg130_provenance.
• NP9511.RA7gmXgKHm97lzVRAjmF0D6QdEvRnZk5wQ684xWKuHxf8130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP9511.RA7gmXgKHm97lzVRAjmF0D6QdEvRnZk5wQ684xWKuHxf8130_provenance.
• NP23227.RA4qSb69hvOYDGpFAzVivL3D9cf0Qjio5JAq5AhyEWPdA130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23227.RA4qSb69hvOYDGpFAzVivL3D9cf0Qjio5JAq5AhyEWPdA130_provenance.
• NP20219.RAkkwqXsWFXgPjcFid4WE0RM-6BC6l1h2rlgNvRVixA6I130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20219.RAkkwqXsWFXgPjcFid4WE0RM-6BC6l1h2rlgNvRVixA6I130_provenance.
• NP34156.RA7SnzGTS7LOeRKCkwzd_kTS9eYwSECjSztDWN3vsjSjg130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP34156.RA7SnzGTS7LOeRKCkwzd_kTS9eYwSECjSztDWN3vsjSjg130_provenance.
• assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP20044.RATPnmBAtqiqi7P2_ZjVH2HM4kAGgTNaD6le5Mxw_xAZE130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20044.RATPnmBAtqiqi7P2_ZjVH2HM4kAGgTNaD6le5Mxw_xAZE130_provenance.
• NP20049.RAa3jmJPvEioMBWbf52_VkrubarF0Fs4rEF2_VHJKzhr4130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20049.RAa3jmJPvEioMBWbf52_VkrubarF0Fs4rEF2_VHJKzhr4130_provenance.
• NP20052.RAalhNiivdir2sV3TEUrfvuHrRMy0iq5Oo3t504_U56Lg130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20052.RAalhNiivdir2sV3TEUrfvuHrRMy0iq5Oo3t504_U56Lg130_provenance.
• NP20054.RAejdk9GDengxErs18LGe_g4C8Ml26kYsvLCeT18S8QMQ130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20054.RAejdk9GDengxErs18LGe_g4C8Ml26kYsvLCeT18S8QMQ130_provenance.
• NP15838.RACWAN2mCXPpjhL723ICgAI6JRzl44_0pxS3gtG_QUSVE130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP15838.RACWAN2mCXPpjhL723ICgAI6JRzl44_0pxS3gtG_QUSVE130_provenance.
• assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP20012.RAJTzkcKySG5QHJPSHQZkGXAzVAT344c-pXqn9vvuX01U130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20012.RAJTzkcKySG5QHJPSHQZkGXAzVAT344c-pXqn9vvuX01U130_provenance.
• NP10812.RABAG0UPDIwFFOoYiLlKQ1AKY7WgZBkaXhUg1GUSFW1LY130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP10812.RABAG0UPDIwFFOoYiLlKQ1AKY7WgZBkaXhUg1GUSFW1LY130_provenance.
• NP14919.RALqA9htQD22YrFZnKFazlKnvkX36L9H5wTUX-5Pig7R8130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP14919.RALqA9htQD22YrFZnKFazlKnvkX36L9H5wTUX-5Pig7R8130_provenance.
• NP20045.RAu24aFzLln-_yK6GeKa-TV0gGoJE6oZMN1PoAlBOww6Q130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20045.RAu24aFzLln-_yK6GeKa-TV0gGoJE6oZMN1PoAlBOww6Q130_provenance.
• NP20048.RAtMjozxPNi3Tkfy9iXORBCJ59CGQD0E2rlLhgNbn6Q88130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20048.RAtMjozxPNi3Tkfy9iXORBCJ59CGQD0E2rlLhgNbn6Q88130_provenance.
• NP20051.RAhWkhRblIv4aBi611lETbuehh53GRMJeML9-viVto1Zs130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20051.RAhWkhRblIv4aBi611lETbuehh53GRMJeML9-viVto1Zs130_provenance.
• NP20046.RAFqf1JEy2JJ9bdVHoxBSm6mZ6_2qr_-qDeE7a_qh6m-k130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20046.RAFqf1JEy2JJ9bdVHoxBSm6mZ6_2qr_-qDeE7a_qh6m-k130_provenance.
• NP20047.RAL8DdWlYHosCLCGLTnJ-aW7fZhDcjjGmkbbRsgd2pd1g130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20047.RAL8DdWlYHosCLCGLTnJ-aW7fZhDcjjGmkbbRsgd2pd1g130_provenance.
• NP20050.RA4kcgXQkpc_GpsSik_1IswkqFXcM2NjnKg0bY7IeduOU130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20050.RA4kcgXQkpc_GpsSik_1IswkqFXcM2NjnKg0bY7IeduOU130_provenance.
• NP20053.RA1_1I-F37ag--9DYPxB8x2Ue9XFoyQM74s0jGx1CeThk130_assertion description "[Carcinogenic susceptibility of rasH2 mice to troglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20053.RA1_1I-F37ag--9DYPxB8x2Ue9XFoyQM74s0jGx1CeThk130_provenance.